Yurdaydin, C. Et Al. 2018. Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study. HEPATOLOGY , vol.67, no.4 , 1224-1236.

Yurdaydin, C., KESKİN, O., KALKAN, Ç., KARAKAYA, M. F., Caliskan, A., KARATAYLI, E., ... Karatayli, S.(2018). Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study. HEPATOLOGY , vol.67, no.4, 1224-1236.

Yurdaydin, Cihan Et Al. "Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study," HEPATOLOGY , vol.67, no.4, 1224-1236, 2018

Yurdaydin, Cihan Et Al. "Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study." HEPATOLOGY , vol.67, no.4, pp.1224-1236, 2018

Yurdaydin, C. Et Al. (2018) . "Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study." HEPATOLOGY , vol.67, no.4, pp.1224-1236.

@article{article, author={Cihan Yurdaydin Et Al. }, title={Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study}, journal={HEPATOLOGY}, year=2018, pages={1224-1236} }